Antibody Response against SARS-CoV-2 and Seasonal Coronaviruses in Nonhospitalized COVID-19 Patients

Authors :: Natalia Ruetalo
Ramona Businger
Karina Althaus
Simon Fink
Felix Ruoff
Michaela Pogoda
Angelika Iftner
Tina Ganzenmüller
Klaus Hamprecht
Bertram Flehmig
Tamam Bakchoul
Markus F. Templin
Michael Schindler
Source :: mSphere, Vol 6, Iss 1 (2021)
Publication Year :: 2021
Publisher :: American Society for Microbiology, 2021.
Abstract: There is strong interest in the nature of the neutralizing antibody response against SARS-CoV-2 in infected individuals. For vaccine development, it is especially important which antibodies confer protection against SARS-CoV-2, if there is a phenomenon called antibody-dependent enhancement (ADE) of infection, and if there is cross-protection by antibodies directed against seasonal coronaviruses.

Full Text Access

Tools